Want to find out what services are available to you?
THE LEADING INDEPENDENT CLINICAL SERVICES PROVIDER
Delivering improved patient outcomes through an experienced team of Clinical Pharmacists.
Interface Clinical Services, an IQVIA business are the largest organisation within the UK healthcare sector to fully employ a team of pharmacists. Working nationally, we operate in partnership with both the NHS and industry.
Disease Prevalence Quality Improvement Programme
Long-term bespoke support packages built for your needs.
Over an agreed period, we will provide on-site and remote support through a combination our Clinical Pharmacist team and technical platforms. The programme aims to help PCNs and ICBs better manage the care of patients with long term conditions, particularly in the wake of COVID-19 and the backlog of care that remains. Clinical capacity is increased while resources such as our Attend2 and QOF Disease Prevalence platforms allow a deep interrogation of practice registers to prioritise patients according to need.
Learn moreHow it works?
These quality improvement programmes begin with a needs assessment so we properly understand the needs of your PCN and ICB. We then build a bespoke package comprised of Attend2 platforms and QOF Disease Prevalence tools as well as Clinical Pharmacist support which can be used for patient coding and training. The programme is delivered incrementally over a period of 6-12 months depending on the PCN preference.
Service areas
Our flagship service supporting practices with register maintenance, disease prevalence and QOF achievement. We have 4 tiers of support available.
Comprised of on-site and remote support from our Clinical Pharmacist teams, we provide clinical tools and resource to help manage patients with long-term conditions. Most reviews include a clinic element to help action urgent care needs identified in screening.
Our Attend2 platforms are purpose built patient management tools available to support a number of therapy areas and support patients with these long-term conditions. Our new IMPACT CVD Prevention platform helps practices and PCNs to achieve their Impact and Investment Fund (IIF) indicators.
These quality improvement programmes begin with a needs assessment so we properly understand the needs of your PCN and ICB. We then build a bespoke package comprised of Attend2 platforms and QOF Disease Prevalence tools as well as Clinical Pharmacist support which can be used for patient coding and training. The programme is delivered incrementally over a period of 6-12 months depending on the PCN preference.
Latest news
Events
Pharmacist-led reviews to proactively manage patients with COPD and overcome the backlog of care
Interface Clinical Services, an IQVIA business presented a poster at the Primary Care Respiratory Society (PCRS) with NHS Leicester, Leicestershire and Rutland Integrated Care…
Articles
Proactive Patient Review in Diabetes
People with type 2 diabetes (T2D) are 50% more likely to die prematurely than those without diabetes1. A common complication of diabetes that can…
Articles
The GP Contract for 2023/24, what has changed, and what does this mean for Primary care?
The GP contract for 2023/24 has been announced. There have been lots of changes, particularly around QOF and access to services. The full statement…
Accolades
Healthcare Pioneer Award with AF Association
Cyber eseentials plus
HSJ Partnership Awards
